Benzodiazepine use in the elderly: The EVA study;Utilisation de benzodiazépines chez le sujet âgé: Données de la cohorte EVA

Revue d'Epidemiologie et de Sante Publique

Volumn 51, Issue 3, 2003, Pages 317-326

  Lechevallier, N ^a   Fourrier, A ^a   Berr, C ^b,c  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b Montpellier 1 University   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Benzodiazepines; Elderly; Pharmaco epidemiology; Psychotropic drugs

Indexed keywords

BENZODIAZEPINE DERIVATIVE; MONOAMINE OXIDASE INHIBITOR; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR;

AGED; ALCOHOL CONSUMPTION; ANXIETY DISORDER; ARTICLE; DEMOGRAPHY; DEPRESSION; DRUG HALF LIFE; DRUG INDICATION; EDUCATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; TRANQUILIZING ACTIVITY;

AGE FACTORS; AGED; ALCOHOL DRINKING; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; COHORT STUDIES; FEMALE; FRANCE; HUMANS; HYPNOTICS AND SEDATIVES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PATIENT COMPLIANCE; QUESTIONNAIRES; SEX FACTORS; SOCIOECONOMIC FACTORS; TIME FACTORS;

EID: 0041424943     PISSN: 03987620     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Legrain M, Lecomte T. La consommation des psychotropes en France et dans quelques pays européens. Bull Acad Natl Med 1997; 181: 1073-87.
2. Ohayon M, Lader M. Use of psychotropic medication in the general population of France, Germany, Italy and the United Kingdom. J Clin Psychiatry 2002; 63: 817-25.
3. Guignon N, Mormiche P, Sermet C. La consommation régulière de psychotropes. INSEE 1994; 310.
4. Fourrier A, Letenneur L, Dartigues JF, Decamps A, Bégaud B. Consommation médicamenteuse chez le sujet âgé vivant à domicile et en institution à partir de la cohorte PAQUID: importance de la polymédication et utilisation des psychotropes. Rev Geriatr 1996; 21: 473-82.
5. Fourrier A, Letenneur L, Dartigues JF, Moore N, Bégaud B. Benzodiazepine use in an elderly community-dwelling population. Characteristic of users and factors associated with subsequent use. Eur J Clin Pharmacol 2001; 57: 419-25.
6. Swartz M, Landerman R, George L, Melville ML, Blazer D, Smith K. Benzodiazepine anti-anxiety agents: prevalence and correlates of use in a southern community. Am J Public Health 1991; 81: 592-6.
7. Mayer-Oakes SA, Kelman G, Beers MH, De Jong F, Matthias R, Atchison KA, et al. Benzodiazepine use in older, community-dwelling southern Californian: prevalence and clinical correlates. Ann Pharmacother 1993; 27: 416-21.
8. Magrini N, Vaccheri A, Parma E, D'Alessandro R, Bottoni A, Occhionero M, et al. Use of benzodiazepines in the Italian general population: prevalence, pattern of use and risk factors for use. Eur J Clin Pharmacol 1996; 50: 19-25.
9. Pariente P, Lepine, JP, Lellouch J. Self-reported psychotropic drug use and associated factors in a French community sample. Psychol Med 1992; 22: 181-90.
10. Kruse WH. Problems and pitfalls in the use of benzodiazepines in the elderly. Drug Saf 1990; 5: 328-44.
11. Paterniti S, Dufouil C, Alpérovitch A. Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study. J Clin Psychopharmacol 2002; 22: 285-93.
12. Hanlon JT, Horner RD, Schmader KE, Fillenbaum GG, Lewis IK, Wall WE, et al. Benzodiazepine use and cognitive function among community-dwelling elderly. Clin Pharmacol Ther 1998; 64: 684-92.
13. Dealberto MJ, Mcavay GJ, Seeman T, Berkman L. Psychotropic drug use and cognitive decline among older men and women. Int J Geriatr Psychiatry 1997; 12: 567-74.
14. Ray W, Griffin MR, Schaffner W, Baugh DK, Melton J. Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987; 316: 363-9.
15. Tillement JP, Albengres E, Cottin D, Klouz A, Arkoub H, Le Louet H. Le risque de chutes lié à l'administration de benzodiazépines seules ou associées, chez le sujet âgé. Therapie 2001; 56: 435-40.
16. Ray WA, Randy LF, Decker MD. Psychoactive drugs and the risk of injurious in motor vehicle crashes in elderly drivers. Am J Epidemiol 1992; 136: 873-83.
17. Dufouil C, Ducimetière P, Alpérovitch A. Sex differences in the association between alcohol consumption and cognitive performance. Am J Epidemiol 1997; 146: 405-12.
18. e éd. Paris, 1993.
19. Furher R, Rouillon F. La version française de l'échelle CES-D (Center for Epidemiologic Studies-Depression Scale). Description et traduction de l'échelle d'auto-évaluation. Psychiatr Psychobiol 1989; 4: 181-90.
20. Spielberger CD, Gorsuch RL, Lushene RE. STAI manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologist Press, 1970.
21. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
22. Paterniti S, Bisserbe J. C, Alpérovitch A. Médicaments psychotropes, anxiété et dépression dans une population âgée. Étude EVA. Rev Epidemiol Sante Publique 1998; 46: 253-62.
23. Simon GE, VonKorff M, Barlow W, Pabiniak C, Wagner E. Predictors of chronic benzodiazepine use in a health maintenance organization sample. J Clin Epidemiol 1996; 49: 1067-73.
24. Shorr RI, Robin DW. Rational use of benzodiazepines in the elderly. Drugs Aging 1994; 4: 9-20.
25. Isacson D, Carsjö K, Bergman U, Blackburn JL. Long-term use of benzodiazepines in a Swedish community: an eight year follow-up. J Clin Epidemiol 1992; 45: 429-36.
26. Pelissolo A, Boyer P, Lépine JP, Bisserbe JC. Épidémiologie de la consommation des anxiolytiques et des hypnotiques en France et dans le monde. Encéphale 1996; 22: 187-96.
27. Waintraub, L. Dépression chez le sujet âgé: diagnostic et traitement. Presse Med 1998; 27: 2129-44.